Rocket Pharmaceuticals (RCKT) Invested Capital (2015 - 2017)

Rocket Pharmaceuticals (RCKT) has 3 years of Invested Capital data on file, last reported at $52.0 million in Q3 2017.

• For the quarter ending Q3 2017, Invested Capital changed 0.0% year-over-year to $52.0 million; the trailing twelve-month figure through Jun 2018 stood at $52.0 million (down 75.0% YoY), and the FY2016 full-year result was $52.0 million, changed N/A from the prior year.
• Invested Capital was little changed at $52.0 million in Q3 2017, from $52.0 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $52.0 million in Q3 2016 to a low of $21.0 million in Q1 2015.
• A 3-year average of $43.1 million and a median of $52.0 million in 2016 frame the typical range for Invested Capital.
• Peak annual rise in Invested Capital reached 0.0% in 2017, while the deepest fall reached 0.0% in 2017.
• Tracing RCKT's Invested Capital over 3 years: stood at $21.0 million in 2015, then surged by 147.62% to $52.0 million in 2016, then changed by 0.0% to $52.0 million in 2017.
• Business Quant data shows RCKT's Invested Capital at $52.0 million in Q3 2017, $52.0 million in Q2 2017, and $52.0 million in Q1 2017.